Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic

por Tagliabue, Fabio, Schena, Daniele, Galassi, Luca, Magni, Matteo, Guerrazzi, Guglielmo, Acerbis, Andrea, Rinallo, Christina, Longhi, Daniel, Ronzani, Alberto, Mariani, Pierpaolo
Publicado 2021

Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience.

por Xue, Elisabetta, Scorpio, Gianluca, Ruggeri, Annalisa, Clerici, Daniela, Farina, Francesca, Campodonico, Edoardo, Acerbis, Andrea, Fiore, Paolo, Bruno, Alessandro, Carrabba, Matteo G, Peccatori, Jacopo, Greco, Raffaella, Stanghellini, Maria Teresa Lupo, Ciceri, Fabio, Corti, Consuelo
Publicado 2023

Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia

por Oltolini, Chiara, Acerbis, Andrea, Orofino, Giorgio, Racca, Sara, Noviello, Maddalena, Dispinseri, Stefania, Clementi, Nicola, Piemontese, Simona, Xue, Elisabetta, Giglio, Fabio, Lupo Stanghellini, Maria Teresa, Diral, Elisa, Bruno, Alessandro, Tassi, Elena, Beretta, Valeria, Marzinotto, Ilaria, Scarlatti, Gabriella, Lampasona, Vito, Ardemagni, Anna, Sampaolo, Michela, Bonini, Chiara, Corti, Consuelo, Peccatori, Jacopo, Castagna, Antonella, Ciceri, Fabio, Greco, Raffaella
Publicado 2023